Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Beauty Health (SKIN) Payables (2020 - 2025)

Beauty Health (SKIN) has disclosed Payables for 6 consecutive years, with $17.3 million as the latest value for Q3 2025.

  • On a quarterly basis, Payables fell 25.08% to $17.3 million in Q3 2025 year-over-year; TTM through Sep 2025 was $17.3 million, a 25.08% decrease, with the full-year FY2024 number at $21.9 million, down 50.99% from a year prior.
  • Payables was $17.3 million for Q3 2025 at Beauty Health, down from $23.0 million in the prior quarter.
  • In the past five years, Payables ranged from a high of $44.8 million in Q4 2023 to a low of $17.3 million in Q3 2025.
  • A 5-year average of $27.7 million and a median of $27.0 million in 2022 define the central range for Payables.
  • Peak YoY movement for Payables: soared 348994.41% in 2021, then tumbled 50.99% in 2024.
  • Beauty Health's Payables stood at $29.0 million in 2021, then dropped by 2.0% to $28.5 million in 2022, then soared by 57.26% to $44.8 million in 2023, then crashed by 50.99% to $21.9 million in 2024, then decreased by 21.18% to $17.3 million in 2025.
  • Per Business Quant, the three most recent readings for SKIN's Payables are $17.3 million (Q3 2025), $23.0 million (Q2 2025), and $23.1 million (Q1 2025).